IN THE HIGH COURT OF GUJARAT AT AHMEDABAD
Vaibhavi D. Nanavati, J.
Nirma Limited Thro' Ajay Bhushanlal Khushu & 1 Others – Applicants
Versus
State Of Gujarat & 1 Others – Respondents
R/Special Criminal Application No. 9870 of 2016
Decided On : 11-10-2022
Drugs and Cosmetics Act - Manufacturing of Not of Standard Quality Drug - Section 16(1)(a), 18(1)(i) r/w section 34 - [Drugs and Cosmetics Act, 1940, Section 16(1)(a), 18(1)(i), 34]
Fact of the Case:
The petitioners, a company engaged in manufacturing drugs and pharmaceutical products, were accused of manufacturing drugs not of standard quality. The complaint alleged that the accused manufactured Geutamicin Injection not of standard quality, and the samples were found to be 'Not of Standard Quality' by the Government Analyst. The accused petitioned for quashing the complaint and the order issuing summons.
Finding of the Court:
The Court found that the reports declaring the product as 'Not of Standard Quality' were based on minor defects, and the product was free from any foreign matter. The accused had stopped manufacturing the product and withdrawn it from the market after receiving a warning from the authority. The Court concluded that the offence alleged was not made out against the petitioners and quashed the complaint and the order issuing summons.
Issues: The issues revolved around the manufacturing of drugs not of standard quality, the validity of the reports declaring the product as such, and the timing of the prosecution launch.
Ratio Decidendi: The Court held that the reports declaring the product as 'Not of Standard Quality' were based on minor defects and that the product was free from any foreign matter. It also considered the delay in launching the prosecution and the warning received by the accused from the authority.
Final Decision: The Court quashed the complaint and the order issuing summons, deeming it fit to do so and finding no fruitful purpose in relegating the petitioners to go through the trial.
JUDGMENT :
1. By way of this present application under Article 226 and 227 of the Constitution of India and under section 482 of the Code of Criminal Procedure 1973, the writ applicants herein have prayed for quashing and setting aside the complaint being Criminal Case No. 4548 of 2015 lodged by the respondent No. 2 before the Chief Judicial Magistrate Court, Viramgam for alleged offences under section 16(1)(a), 18(1)(i) r/w section 34 and punishable under section 27 of the Drugs and Cosmetics Act, 1940 and the order passed by the learned Chief Judicial Magistrate, Viramgam issuing summons to the petitioners.
2. The facts giving rise to the filing of the present petition reads as under:-
2.1 The petitioner No. 1 is a company incorporated under the provisions of Company’s Act, 1956 and is engaged in the manufacturing and sale of Soda Ash, Linear Alkaline Benzene, Soaps and Detergents and Cement at various locations in the State of Gujarat and in India.
2.2 The petitioner No. 1 was also engaged in manufacturing drugs and pharmaceuticals at village Sachana Taluka Viramgam, Gujarat. The petitioner No. 2 is the accused No. 2 in the complaint being Criminal Case No. 4548 of 2015 and is the Managing Director of petitioner No. 1 – Company.
2.3 The petitioner No. 1 was manufacturing drugs and pharmaceutical products under a license bearing No. G/28/1221 granted by the Food and Drugs Control Administration, Gujarat to manufacture for sale (or for distribution) of drugs specified in Schedule thereto for a period of 5 years from 20.06.2006 to 19.06.2011. The same came to renewed on 29.12.2011 for a period of another 5 years from 20.06.2011 to 19.06.2016.
2.4 The petitioner No. 1 was manufacturing Geutamicin Injection under the brand Nirgent. The same was also added in the list of approved produces as per the Form-28 after issuance of license. The Healthcare Division of petitioner No. 1 was demerged and transferred into Aculife Healthcare Private Limited vide order of this Court dated 20.04.2015. After the demerger of the Healthcare Division, the license under Form 8 dated 29.12.2011 was canceled on 05.10.2015 by Food and Drugs Control Administration, Gujarat and pursuant to which the petitioner stopped manufacturing Drugs and Pharmaceutical products.
2.5 The impugned complaint came to be filed against the writ applicants by the respondent No. 2 on 02.11.2015. It is stated that before or after the impugned complaint filed by the respondent No. 2 – Drug Inspector being Criminal Case No. 4548 of 2015, there is no such incident which had occurred after the strict warning given by the Food and Drugs Control Department, Gujarat vide letter dated 10.11.2015, which is issued under the order dated 25.10.2015.
3. It is the case of the complainant – respondent No. 2 that the accused No. 1 manufactured drugs not of standard quality being Nirgent-10ml (Geutamicin Injection IP) Batch No. 5L20980, Mg. Date 12/2012, Expiry Date 11/2014 Manufactured by M/s Nirma Limited (Healthcare Division) Sachana Gujarat. It is also the case of the complainant that the accused No. 1 had supplied the said batch of drug as per the list submitted. The samples of the aforesaid drugs along with the other samples were drawn by Shri Virendra Singh, Drugs Inspector on 28.09.2013 from the custody of Mr. Deepak Bhatt – accused No. 3 under the provisions of Drugs and Cosmetics Act. The said collected drug were divided into three equal portions (under section 23 of the Act) and it was effectively sealed packed and suitably marked. The intimation in writing was duly filled up relevant Form No. 17 and Form No. 17-A along with one sealed potions of the sample which was handed over to accused No. 3 and the same was acknowledged and signed. Out of the two samples which were retained by Shri Virendra Singh – Drug Inspector one portion of sealed sample was sent for test/analysis to the Government Analyst, Central Drugs Laboratory, Kolkata in a sealed packet. Thereafter, the sample was tes
The main legal point established in the judgment is that the prosecution for manufacturing drugs not of standard quality may not be launched if the product is free from any foreign matter and the def....
The court's decision emphasized the importance of considering the actual quality of the product, the timing of the launch of prosecution, and the availability of administrative measures for minor def....
The prosecution of drug quality violations is unsustainable when testing delays invalidate the accused's rights to challenge the results, highlighting the need for timely compliance under the Drugs a....
The main legal point established in the judgment is the need for specific allegations to establish vicarious liability and the importance of following mandatory provisions before launching prosecutio....
The main legal point established in the judgment is the conclusive nature of the State Analyst Report and the requirement to exercise the statutory right to request re-analysis by the Central Drugs L....
Quash of Criminal proceedings - once it is shown that the right of accused to adduce evidence in controversion of the Government Analyst’s report is defeated due to acts and omission of the Drugs Ins....
The judgment establishes that a valuable right to re-test a drug sample, as provided under Section 25(4) of the Drugs and Cosmetics Act, cannot be denied without due process, and failure to comply wi....
The right of the petitioner to adduce evidence under sub sections 3 and 4 of section 25 of the Drugs and Cosmetics Act was crucial in influencing the court's decision to quash the entire criminal pro....
Login now and unlock free premium legal research
Login to SupremeToday AI and access free legal analysis, AI highlights, and smart tools.
Login
now!
India’s Legal research and Law Firm App, Download now!
Copyright © 2023 Vikas Info Solution Pvt Ltd. All Rights Reserved.